A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Conditions: Cardiovascular Diseases; Type 2 Diabetes Mellitus Interventions: Drug: Apelin; Drug: Relaxin; Drug: Normal saline; Diagnostic Test: Verapamil; Diagnostic Test: LN Monomethyl arginine Sponsors: Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; AstraZeneca; MedImmune LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2018 Category: Research Source Type: clinical trials